New AI Model Based on 3D CT Scans Improves Accuracy of Machine Learning in COVID-19 Diagnosis
|
By HospiMedica International staff writers Posted on 17 Dec 2021 |

Researchers have developed an artificial intelligence (AI) model that can diagnose COVID-19 as well as a panel of professional radiologists, while preserving the privacy of patient data.
An international team of researchers, led by the University of Cambridge (Cambridge, England) and the Huazhong University of Science and Technology (Hubei, China), used a technique called federated learning to build their model. Using federated learning, an AI model in one hospital or country can be independently trained and verified using a dataset from another hospital or country, without data sharing. The researchers based their model on more than 9,000 CT scans from approximately 3,300 patients in 23 hospitals in the UK and China. Their results provide a framework where AI techniques can be made more trustworthy and accurate, especially in areas such as medical diagnosis where privacy is vital.
AI has provided a promising solution for streamlining COVID-19 diagnoses and future public health crises. However, concerns surrounding security and trustworthiness impede the collection of large-scale representative medical data, posing a challenge for training a model that can be used worldwide. In the early days of the COVID-19 pandemic, many AI researchers worked to develop models that could diagnose the disease. However, many of these models were built using low-quality data, ‘Frankenstein’ datasets, and a lack of input from clinicians. Many of the same researchers from the current study highlighted that these earlier models were not fit for clinical use in the spring of 2021.
The international team of researchers used two well-curated external validation datasets of appropriate size to test their model and ensure that it would work well on datasets from different hospitals or countries. The researchers based their framework on three-dimensional CT scans instead of two-dimensional images. CT scans offer a much higher level of detail, resulting in a better model. They used 9,573 CT scans from 3,336 patients collected from 23 hospitals located in China and the UK.
The researchers also had to mitigate for bias caused by the different datasets, and used federated learning to train a better generalized AI model, while preserving the privacy of each data centre in a collaborative setting. For a fair comparison, the researchers validated all the models on the same data, without overlapping with the training data. The team had a panel of radiologists make diagnostic predictions based on the same set of CT scans, and compared the accuracy of the AI models and human professionals. The researchers say their model is useful not just for COVID-19, but for any other diseases that can be diagnosed using a CT scan.
“AI has a lot of limitations when it comes to COVID-19 diagnosis, and we need to carefully screen and curate the data so that we end up with a model that works and is trustworthy,” said co-first author Hanchen Wang from Cambridge’s Department of Engineering.
“Before COVID-19, people didn’t realize just how much data you needed to collect in order to build medical AI applications,” said co-author Dr. Michael Roberts from AstraZeneca and Cambridge’s Department of Applied Mathematics and Theoretical Physics. “Different hospitals, different countries all have their own ways of doing things, so you need the datasets to be as large as possible in order to make something that will be useful to the widest range of clinicians.”
Related Links:
University of Cambridge
Huazhong University of Science and Technology
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
AI Tool Predicts Unplanned Care and Symptom Burden in Cancer Survivors
Unplanned emergency visits and hospitalizations remain common in cancer survivorship, when routine clinical contact often tapers while new symptoms emerge. These events reflect unmet needs and disrupt... Read moreCritical Care
view channel
Home Blood Pressure Telemonitoring Linked to Fewer Cardiovascular Events
Hypertension is a leading cause of myocardial infarction and stroke, yet it often progresses without symptoms. Uncontrolled blood pressure contributes to avoidable hospitalizations, deaths, and health system burden.... Read more
Tiny Wearable Patch Tracks Heart and Respiratory Changes at Home
Auscultation and cardiorespiratory monitoring are typically limited to brief, clinic-based assessments. These intermittent checks can miss evolving abnormalities and place added burden on patients who... Read moreSurgical Techniques
view channel
Expandable Lumbar Fusion System Gains FDA 510(k) Clearance
Xenix Medical (Orlando, FL, USA) has received U.S. Food and Drug Administration 510(k) clearance and initiated full commercial launch of the Lux Expandable Lumbar Interbody Fusion System.... Read more
New CAR T-Cell Therapy Enables Transplants in Hard-to-Match Kidney Patients
Highly sensitized kidney transplant candidates have extremely high levels of anti-donor antibodies that block matching and prolong dialysis. These patients face long wait times and increased morbidity... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
AI-Native EHR Achieves EU Medical Device Certification
InterSystems (Boston, MA, USA) announced that its IntelliCare electronic health record (EHR) solutions have been certified as Class IIa medical devices under the European Union Medical Device Regulation... Read more
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read morePoint of Care
view channel
Handheld AI Device for Point-of-Care Skin Lesion Assessment Receives CE Mark
DermaSensor (Miami, FL, USA) has received a Class IIb CE Mark for its handheld DermaSensor device, marking the start of the company’s global expansion strategy. The certification demonstrates conformity... Read more
Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing
Proxim Diagnostics Corp. (Santa Clara, CA, USA) has announced that its Profile System, a handheld point-of-care immunoassay platform, has completed development. The milestone includes completion... Read more
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more








